Match Document Document Title
US20120028936 ORAL CONTRACEPTION WITH TRIMEGESTONE  
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the...
US20130029947 PROGESTERONE CONTAINING ORAL DOSAGE FORMS AND KITS  
The present invention provides for progesterone containing pharmaceutical oral dosage forms, pharmaceutical kits, and related methods. In one embodiment, an oral dosage form formulated for...
US20120021041 TRANSDERMAL DELIVERY  
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
US20110256211 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
US20130224268 TOPICAL DELIVERY OF HORMONAL AND NON HORMONAL NANO FORMULATIONS, METHODS OF MAKING AND USING THE SAME  
The present invention relates to methods for treating, preventing, minimizing, and/or diminishing signs of aging in the skin comprising topically administering to the subject in need thereof a...
US20110046095 STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM  
The present invention relates to steroid hormone products, such as oral contraceptive products, including at least one steroid active ingredient mixed with an excipient and having improved...
US20150071857 STEROID HORMONE AND CHOLESTEROL PATHWAYS AS ONE UNIFIED HOMEOSTATIC SYSTEM  
A unified homeostatic system of cholesterol and steroid hormone pathways is described, in which the uses or modulations of function of the homeostatic system of cholesterol and steroid hormone...
US20150094287 VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT  
The present invention relates to a very low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5...
US20130140210 LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT  
The present invention relates to a low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5 mg...
US20130137664 LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT  
The present invention relates to a very low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5...
US20110275601 VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT  
The present invention relates to a very low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5...
US20110256210 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a monthly treatment cycle with a fixed treatment interval and a variable rest interval.
US20110172197 Dosace Form For Hormonal Contraceptive  
A dosage form for hormonal contraception containing a given number of hormone-containing daily units and a given number of hormone-free daily units for daily, oral administration, where the...
US20150037395 TRANSDERMAL HORMONE DELIVERY SYSTEM: COMPOSITIONS AND MTEHODS  
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for control of fertility and as therapy for a variety of diseases and conditions treatable by robust delivery of...
US20130280213 ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES  
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including:...
US20120201747 System and Method for Diagnosis and Treatment  
This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy...
US20120142645 NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE FOR LOWERING CHOLESTEROL  
Methods for ameliorating a symptom associated with hypercholesterolemia, hyperlipidemia, or both in a subject. In some embodiments, the methods include administering to a subject in need thereof...
US20110288059 NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR  
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder in a subject. Also provided are methods for ameliorating at least one physical symptom or at least one psychological...
US20140182597 TRANSDERMAL DRUG DELIVERY SYSTEMS FOR LEVONORGESTREL AND ETHINYL ESTRADIOL  
Described are transdermal drug delivery systems for the transdermal administration of levonorgestrel and ethinyl estradiol, comprising an acrylic polymer matrix. Methods of making and using such...
US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use  
The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a...
US20120322777 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology  
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
US20100298279 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology  
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
US20140088050 USE OF ANDROGEN FOR DISEASE TREATMENT  
By lowering and then after raising the amount of SHBG in the body, an effective method for treatment of various diseases is achieved. First and seconds androgens, namely, anabolic steroids are...
US20110053900 PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER  
The subject matter of the instant invention is pertinent to the field of cancer treatment. In particular, the instant invention is relevant to the treatment and/or prevention of breast cancer in a...
US20150231154 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING NORELGESTROMIN FOR CONTRACEPTION AND HORMONE REPLACEMENT  
The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to...
US20150196568 SYSTEM FOR USE BY COMPOUNDING PHARMACISTS TO PRODUCE HORMONE REPLACEMENT MEDICINE CUSTOMIZED FOR EACH CUSTOMER  
This invention provides a system for compounding a pharmaceutical product for hormone replacement therapy. The system has a set of concentrated reagent compositions, each containing one or more...
US20110071122 System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer  
This invention provides a system for compounding a pharmaceutical product for hormone replacement therapy. The system has a set of concentrated reagent compositions, each containing one or more...
US20110251163 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a variable treatment cycle and a variable rest interval.
US20150157572 PROLIPOSOMAL TESTOSTERONE FORMULATIONS  
Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder...
US20140112986 PROLIPOSOMAL TESTOSTERONE FORMULATIONS  
Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder...
US20120263784 EMERGENCY CONTRACEPTIVE  
The present invention discloses an emergency contraceptive formulation for nasal and/or pulmonary administration comprising of levonorgestrel optionally in combination with ethylestradiol. The...
US20140179646 HORMONE DELIVERY SYSTEM AND METHOD  
A hormone delivery system and method are provided for administering bioidentical human hormones using a combination of modalities for the treatment of human physiological conditions.
US20140010806 Treatment of Ocular Diseases  
The invention relates to methods to use 17α-ethynylandrost-5-ene-3β,7β,17β-triol to treat ocular diseases or conditions such as dry eye, uveitis or retinitis. The compound can be administered...
US20140072615 TRANSDERMAL HORMONE DELIVERY SYSTEM: COMPOSITIONS AND METHODS  
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for control of fertility and as therapy for a variety of diseases and conditions treatable by robust delivery of...
US20150157646 Abiraterone Steroid Formulation  
A nanoparticulate composition of abiraterone acetate that allows treatment at a lower dose than convention abiraterone acetate formulations is described as in a method of treating prostate cancer...
US20130210783 NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR  
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder. Also provided are methods for ameliorating at least one symptom resulting from tobacco cessation; and for...
US20140056848 Method for the Treatment of Multiple Sclerosis  
A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to...
US20150246060 Abiraterone Acetate Formulation and Methods of Use  
Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
US20110189293 THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS  
A method for treating an immunoinflammatory disorder in a subject in need thereof, said method comprising administering to said subject a unit dosage form comprising dipyridamole coated onto acid...
US20140107082 Method and Compositions for Treating Psoriasis  
Method and composition for treating psoriasis and other skin disorders.
US20140329783 TRANSDERMAL HORMONE REPLACEMENT THERAPIES  
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via...
US20130338122 TRANSDERMAL HORMONE REPLACEMENT THERAPIES  
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via...
US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof  
The present invention relates to the use of D-chiroinositol or a phosphate thereof in combination with folate for the reduction or prevention of congenital deformations such as anorectal...
US20120237502 METHOD FOR TREATING BREAST CANCER AND OVARIAN CANCER  
The present invention relates to a method for the prevention or treatment of certain breast cancers or ovarian cancer comprising administering to a patient in need thereof of a therapeutically...
US20120289486 TREATMENT OF EYELID DERMATITIS  
A method for the treatment of eyelid dermatitis and/or dermatitis of the periorbital area is provided.
US20110245211 METHOD FOR CONTRACEPTION  
The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low...
US20140256690 CONTRACEPTIVE METHOD  
A transdermal drug delivery device for reducing the risk of pregnancy in overweight women is disclosed. Methods of using the device are also disclosed. When used in accordance with the disclosed...
US20130116217 NEUROPROTECTION AND MYELIN REPAIR USING NESTORONE®  
Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and...
US20110124611 METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION  
The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The...
US20120231052 NEUROPROTECTION AND MYELIN REPAIR USING NESTORONE®  
Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and...